Navigation Links
Dr. Jonathan White Joins Haemonetics as Head of Research and Development
Date:12/8/2008

BRAINTREE, Mass., Dec. 8 /PRNewswire-FirstCall/ --Haemonetics announced today that Dr. Jonathan White will join the Company as head of Research and Development, Vice President of Haemonetics, effective December 8, 2008. In this role, Dr. White will have global responsibility for leading development of the next generation of products to complement Haemonetics' blood management solutions portfolio.

Brad Nutter, Haemonetics' Chairman and CEO, said, "As the global leader in blood management solutions for our customers, we are continually strengthening our product suite with medical devices, information management platforms, and services for blood collectors and hospitals to reduce costs and improve patient outcomes. Dr. White has an extraordinary portfolio of skills and a diverse background which will strengthen our blood management R&D initiatives. We are pleased to welcome him to Haemonetics."

Prior to joining Haemonetics, Dr. White worked for Pfizer Inc. and spent 10 years in a variety of progressive roles encompassing: strategy and business development, leadership of the information technology function, and building R&D platforms for innovation. He led the integration of the R&D organizations of Pfizer and Warner-Lambert Pharmaceutical Company following Pfizer's acquisition of Warner-Lambert. He also served as Chief Innovation Officer for Pfizer. Prior to this, Dr. White worked for McKinsey & Company as a management consultant, where he worked for 6 years in its global healthcare practice serving a variety of clients (including Pfizer) in Europe, China, Africa and the U.S.

Mr. Nutter added, "Dr. White's global business acumen, medical background, strategic thinking, and innovation skills coupled with his knowledge and experience in information technology and consulting services ideally prepare him to play a key role in Haemonetics' leadership team as we build our vision for Blood Management Solutions."

Dr. White, age 49, completed his education and early work as a physician in the United Kingdom. He is a certified neurosurgeon who has worked in both clinical and academic medical settings. He also holds a Masters in Computer Science from Cambridge University as well as a Masters in Business Administration from INSEAD in France.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
2. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
3. Emmy Winner Jonathan Jackson With Rock Band Enation Take On Predators & Rapists
4. Ability to cope with stress can increase good cholesterol in older white men, study finds
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
7. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
8. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
9. Older blacks and Latinos still lag whites in controlling diabetes
10. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
11. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... Gevir, a New ... antler velvet, announced its products are coming soon to Amazon.com, the world’s largest online ... Thomson as a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... treatment to the thousands of individuals who have recently fallen victim to America’s opioid ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes customized ... room, fewer hospital admissions, and better blood pressure and glycemic control, a ... study can be found here . , The study comes as health ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology: